)
)
Aptahem Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Aptahem
Access all reports
Aptahem AB is a Sweden-based biotechnology company specializing in the development of innovative therapies for severe and acute conditions. The company focuses on drug candidates that target inflammatory and coagulation disorders, such as sepsis and other life-threatening diseases. The company is headquartered in Malmö, Sweden, and its shares are listed on the Spotlight Stock Market.
Latest articles
)
Robert G. Hagstrom: Darwinian Investing and Multidisciplinary Wisdom
Robert G. Hagstrom, author of The Warren Buffett Way, explores how interdisciplinary thinking shapes his investing, from Adler's reading to Darwinian markets.
7 Feb 2025
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Ticker symbol
APTA
Country
🇸🇪 Sweden